pharma · Ovarian Neoplasms · Stage 3 or 4 Non-mucinous Epithelial Ovarian Cancer
TESARO Bio Netherlands
TESARO Bio Netherlands B.V.
News and analysis for TESARO Bio Netherlands on NovaPharmaNews — regulatory, clinical, and market coverage.
EU HQ
EMA registrant Type
Company details
- Status
- Public
- HQ
- EU
- Programs
- 6
- Drugs
- 23
- Patents
- 0
News & analysis
NovaPharmaNews articles mentioning TESARO Bio Netherlands — regulatory, clinical, and market coverage.
News and analysis for TESARO Bio Netherlands on NovaPharmaNews — regulatory, clinical, and market coverage.